Elevated Amniotic Fluid Stromal Cell-derived Factor-1α (SDF-1α) Concentration in Mid-gestation as a Predictor of Adverse Birth Outcomes

Journal of the Chinese Medical Association

Volumn 72, Issue 12, 2009, Pages 638-642

  Tseng, Jenn Jhy ^a,b,c   Chen, Ya Fang ^a   Hsieh, Yeun Ting ^a   Chou, Min Min ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b HUNGKUANG UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

amniotic fluid; gestational diabetes; pre eclampsia; pregnancy; stromal cell derived factor 1

Indexed keywords

STROMAL CELL DERIVED FACTOR 1ALPHA;

AMNIOCENTESIS; AMNION FLUID; APGAR SCORE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HIGH RISK PATIENT; HUMAN; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MATERNAL AGE; MULTIVARIATE ANALYSIS; PLACENTA DISORDER; PREDICTION; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE LABOR; RECEIVER OPERATING CHARACTERISTIC; REGRESSION ANALYSIS; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE;

ADULT; AMNIOTIC FLUID; APGAR SCORE; CHEMOKINE CXCL12; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; MULTIVARIATE ANALYSIS; PREGNANCY; PREMATURE BIRTH;

EID: 74249088065     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/S1726-4901(09)70446-0     Document Type: Article

References (17)

1. Hunt J.S., Petroff M.G., and Burnett T.G. Uterine leukocytes: key players in pregnancy. Stem Cell Dev Biol 11 (2000) 127-137
2. Heikkinen J., Mottonen M., Pulkki K., Lassila O., and Alanen A. Cytokine levels in midtrimester amniotic fluid in normal pregnancy and in the prediction of pre-eclampsia. Scand J Immunol 53 (2001) 310-314
3. Zourbas S., Dubanchet S., Marta J., and Chaouat G. Localization of pro-inflammatory (IL-12, IL-15) and anti-inflammatory (IL-11, IL-13) cytokines at the fetomaternal interface during murine pregnancy. Clin Exp Immunol 126 (2000) 519-528
4. Rollins B.J. Chemokines. Blood 90 (1997) 909-928
5. Murphy P.M., Baggiolini M., Charo I.F., Hébert C.A., Horuk R., Matsushima K., Miller L.H., et al. Internatalunion of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52 (2000) 145-176
6. Nagasawa T., Hirota S., Tachibana K., Takakura N., Nishikawa S., Kitamura Y., Yoshida N., et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382 (1996) 635-638
7. Wu X., Li D.J., Yuan M.M., Zhu Y., and Wang M.Y. The expression of CXCR4/CXCL12 in first-trimester human trophoblast cells. Biol Reprod 70 (2004) 1877-1885
8. Yang Y., Zou L., Li M., and Zhao Y. CXCL12/CXCR4 expression in trophoblasts takes part in materno-fetal immune tolerance and vascular remodeling. J Huazhong Univ Sci Technolog Med Sci 26 (2006) 466-468
9. Brooks Jr. H.L., Caballero Jr. S., Newell C.K., Steinmetz R.L., Watson D., Segal M.S., Harrison J.K., et al. Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone. Arch Ophthalmol 122 (2004) 1801-1807
10. De La Luz Sierra M., Yang F., Narazaki M., Salvucci O., Davis D., Yarchoan R., Zhang H.H., et al. Differential processing of stromal-derived factor-1α and stromal-derived factor-1β explains functional diversity. Blood 103 (2004) 2452-2459
11. st edition (2005), McGraw-Hill, New York 760-808
12. st edition (2005), McGraw-Hill, New York 1169-1188
13. Lee P.A., Chernausek S.D., Hokken-Koelega A., and Czernichow P. International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24-October 1, 2001. Pediatrics 111 (2003) 1253-1261
14. Jaleel M.A., Tsai A.C., Sarkar S., Freedman P.V., and Rubin L.P. Stromal cell-derived factor-1 (SDF-1) signalling regulates human placental trophoblast cell survival. Mol Hum Reprod 10 (2004) 901-909
15. Bjercke S. Normal implantation is important in order to avoid pregnancy complications and diseases later in life. Tidsskr Nor Laegeforen 119 (1999) 3903-3908
16. Guzin K., Tomruk S., Tuncay Y.A., Naki M., Sezginsoy S., Zemheri E., Yucel N., et al. The relation of increased uterine artery blood flow resistance and impaired trophoblast invasion in pre-eclamptic pregnancies. Arch Gynecol Obstet 272 (2005) 283-298
17. Catanzarite V.A., Stanco L.M., Schrimmer D.R., and Conroy C. Managing placenta previa/accreta. Contemp Obstet Gynecol 41 (1996) 66-95